UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,779,035 | +47.7% | 1,197,647 | +9.1% | 0.00% | – |
Q2 2023 | $11,363,431 | +332.2% | 1,097,916 | +285.9% | 0.00% | – |
Q1 2023 | $2,629,140 | -15.1% | 284,539 | -18.5% | 0.00% | – |
Q4 2022 | $3,098,025 | +8.0% | 349,270 | +1.3% | 0.00% | – |
Q3 2022 | $2,868,000 | +2.9% | 344,778 | +1.3% | 0.00% | – |
Q2 2022 | $2,788,000 | -81.2% | 340,412 | -80.0% | 0.00% | – |
Q1 2022 | $14,816,000 | -9.8% | 1,700,776 | -1.6% | 0.00% | – |
Q4 2021 | $16,434,000 | -42.9% | 1,728,094 | +0.9% | 0.00% | -100.0% |
Q3 2021 | $28,800,000 | +9.2% | 1,712,223 | -0.9% | 0.00% | 0.0% |
Q2 2021 | $26,372,000 | -19.0% | 1,727,039 | +3.4% | 0.00% | 0.0% |
Q1 2021 | $32,544,000 | +18.1% | 1,670,605 | +9.2% | 0.00% | 0.0% |
Q4 2020 | $27,561,000 | -3.8% | 1,529,491 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $28,657,000 | -25.2% | 1,485,601 | +1.4% | 0.00% | -50.0% |
Q2 2020 | $38,288,000 | +53.6% | 1,465,805 | +4.9% | 0.00% | +100.0% |
Q1 2020 | $24,922,000 | -45.6% | 1,396,976 | +1.8% | 0.00% | -50.0% |
Q4 2019 | $45,811,000 | +37.8% | 1,372,863 | -1.6% | 0.00% | +100.0% |
Q3 2019 | $33,242,000 | -30.9% | 1,394,930 | +4.2% | 0.00% | -50.0% |
Q2 2019 | $48,107,000 | +208.2% | 1,338,553 | +216.8% | 0.00% | +100.0% |
Q1 2019 | $15,610,000 | +20.8% | 422,583 | +40.8% | 0.00% | 0.0% |
Q4 2018 | $12,919,000 | +166.5% | 300,029 | +192.4% | 0.00% | – |
Q3 2018 | $4,847,000 | +8.5% | 102,619 | +14.3% | 0.00% | – |
Q2 2018 | $4,468,000 | – | 89,790 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |